Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Citracal Prenatal + docosahexaenoic acid is a combination nutritional supplement specifically formulated for use during pregnancy and the postnatal period. It typically consists of a multivitamin and mineral tablet paired with a separate softgel containing docosahexaenoic acid (DHA). The multivitamin component provides essential nutrients, including calcium (as calcium citrate), iron (often as carbonyl iron), and folic acid. Calcium citrate is utilized for its high bioavailability and ability to be absorbed regardless of food intake, supporting maternal bone density and fetal skeletal development. Folic acid is critical for DNA synthesis and the prevention of neural tube defects. The DHA component, an omega-3 fatty acid, is a primary structural element of the fetal brain and retina, playing a vital role in neurological and visual development. Originally marketed by Bayer as a prescription-strength prenatal option, it was designed to provide comprehensive nutritional support exceeding standard over-the-counter formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Citracal Prenatal + docosahexaenoic acid.